First pill to fight Covid-19 approved for use in the UK
The first pill for Covid-19 treatment, Molnupiravir made by MSD, has been approved for use in the UK by the MHRA.
Source: ilfordrecorder.co.uk
📰 Merck Sharp News
Page 125 - Merck Sharp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Merck Sharp. Real-time updates on events, politics, business and more.
Stingthera, Inc. Announces Clinical Collaboration with Merck to Evaluate SNX281 in Combination ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Alkermes to Present Data on Nemvaleukin Alfa at the Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced plans to present a poster related to nemvaleukin alfa (nemvaleukin), the companys novel,...
United States Brian Gastman Sandy Coombs Sourojit Bhowmick Society For Immunotherapy Of Cancer Merck Sharp Dohme Corp
Source: prnewswire.com
Quick, high-yield synthesis of molnupiravir, an investigational COVID antiviral pill
“Engineered Ribosyl-1-Kinase Enables Concise Synthesis of Molnupiravir, an Antiviral for COVID-19”ACS Central Science As SARS-CoV-2 continues to
Source: miragenews.com
Covid-19 news: One in four infected adults in England aren't isolating
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic
Source: newscientist.com
Epidemiology of type 2 diabetes remission in Scotland in 2019: A cross-sectional population-based study
Mireille Captieux and co-workers report on population-level evidence for remission of type 2 diabetes in Scotland.
United Kingdom United States Ronaldcw Ma Eli Lilly Boehringer Ingelheim American Diabetes Association
Source: plos.org
Covid-19 news: Global coronavirus toll hits 5 million recorded deaths
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic
Source: newscientist.com
Intech testing new asthma inhaler with eye on US market
Intech Biopharm Corp (益得生技) has started testing the effects of a metered-dose inhaler generic of Teva Pharmaceutical Industries Ltd’s ProAir, and expects to gain marketing approval by 2023, it said yesterday. The company, which developed SYN011 to treat acute asthma, received approval from the US Food and Drug Administration in August to study the biochemical and physiological effects of the drug in a phase 3 clinical trial, Intech spokesperson Hugues Hung (洪堯國) told the Taipei T...
Source: taipeitimes.com
Covid-19 news: Fully vaccinated can still get covid-19 from household
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic
Source: newscientist.com
UNAIDS welcomes landmark agreement between Medicines Patent Pool and Merck Sharp & Dohme
UNAIDS welcomes the agreement between the Medicines Patent Pool (MPP) and the pharmaceutical company Merck Sharp & Dohme through which the intellectual property rights over an antiviral medicine to treat mild to moderate forms of COVID-19 in adult patients are shared with interested sub-licensees on a non-exclusive and transparent basis. The new medicine, molnupiravir, is
Winnie Byanyima World Health Organization Technology Access Pool Medicines Patent Pool Merck Sharp Executive Director
Source: unaids.org